As attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has informed BSE that Mr. Jitendra Somchand Shah, a Non-Executive Independent Director (DIN: 01609325), has turned 75 years old on September 22, 2025. Under SEBI LODR Regulation 17(1A), any director crossing 75 years needs shareholder approval to continue on the board. The company will seek this approval through a Postal Ballot. Mr. Shah, who has over 42 years of experience in marketing, corporate sales, and business development, was originally appointed as Independent Director for a 5-year term at the 31st AGM held on September 30, 2024. The company confirmed he is not debarred by any SEBI order from holding the director's position.
This is a routine regulatory compliance disclosure and not a negative event. Shareholders will get to vote on whether Mr. Shah continues on the board; his continuation would maintain board continuity and his marketing expertise, while rejection could create a vacancy needing a new independent director. No material impact on stock price is expected.